About
Back
About Us
Management Team
Board of Directors
Supervisory Committee
Clinical Advisors
Factsheet
Pipeline
Back
Pipeline
VDA-1102 Ointment
VDA-1102 IV
VDA-1275
Therapeutic Areas
Back
Oncology
Back
Solid Tumors
Cutaneous T-Cell Lymphoma (CTCL)
Dermatology
Back
Skin Cancer
Cutaneous Squamous Cell Carcinoma (cSCC)
Actinic Keratosis
Clinical Trials
Technology
Back
HK2 in Cancer
VDAC/HK2
VDAC/HK2 Modulators
Immuno-Metabolism
News & Events
Back
Press Releases
Events
Publications
Factsheet
Investor Relations
Contact
About
Back
About Us
Management Team
Board of Directors
Supervisory Committee
Clinical Advisors
Factsheet
Pipeline
Back
Pipeline
VDA-1102 Ointment
VDA-1102 IV
VDA-1275
Therapeutic Areas
Back
Oncology
Back
Solid Tumors
Cutaneous T-Cell Lymphoma (CTCL)
Dermatology
Back
Skin Cancer
Cutaneous Squamous Cell Carcinoma (cSCC)
Actinic Keratosis
Clinical Trials
Technology
Back
HK2 in Cancer
VDAC/HK2
VDAC/HK2 Modulators
Immuno-Metabolism
News & Events
Back
Press Releases
Events
Publications
Factsheet
Investor Relations
Contact
News & Events
BIO Investor Forum, October 17-18, 2018 | San Francisco, California
https://www.bio.org/events/bio-investor-forum
LiveSites
|
Login
© 2016 - 2022 Vidac
To Top
